On February 9, Healthblooming Limited purchased an additional 1.2 million shares of BrainAurora-B (06681). The transaction was executed at a price of HK$4.6927 per share, resulting in a total consideration of approximately HK$5.63 million. Following this acquisition, the firm's total shareholding has increased to 82.104 million shares, representing a 6.04% stake in the company. The transaction involved another related party: Zhao Yujie.
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.